Skip to content
    C

    CPE

    Beijing, China
    LinkedIn
    Biotech & Life SciencesHardware & Semiconductors

    CPE (formerly CITIC Private Equity) is a Chinese alternative investment firm that employs a long-term vision and value investment strategy. It primarily focuses on investments in the technology and industrial, consumer and healthcare, and infrastructure sectors.

    50% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-d (50% of deals).

    Find people at CPE on Goldilocks AI

    Portfolio

    2

    Fund Size

    $14B

    Top Stage

    Series D

    Last 12 Mo

    0

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Portfolio

    2 investments
    CompanyRoundAmountDate
    Insilico Medicine logoInsilico MedicineSeries C$255MJun 2021
    Hesai logoHesaiSeries D$300MJun 2021

    Top Co-Investors

    GL Ventures1 shared
    Xiaomi1 shared
    Meituan1 shared
    Lightspeed China Partners1 shared
    Sequoia Capital1 shared
    Warburg Pincus1 shared
    Pavilion Capital1 shared
    Eight Roads Ventures1 shared
    Lilly Asia Ventures1 shared
    Sinovation1 shared
    Bold Capital Partners1 shared
    Baidu Venture1 shared
    OrbiMed1 shared
    Mirae Asset1 shared
    B Capital1 shared
    Deerfield1 shared
    Lake Bleu Capital1 shared
    Sequoia China1 shared
    Sage1 shared

    Last updated: 16 April 2026